Screener
IYH vs IBB
iShares U.S. Healthcare ETF vs iShares Biotechnology ETF
Key differences
- IYH costs 0.06% less per year.
- Over the last 3 years, IBB has delivered higher annualized returns.
Side-by-side comparison
| IYH | IBB | |
|---|---|---|
| Annual cost (TER) | 0.38% | 0.44% |
| Fund size (AUM) | $2.8B | $7.9B |
| Since | 2000 | 2001 |
| Dividend yield | 1.31% | 0.23% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +16.1% | +39.0% |
| CAGR 3Y | +5.8% | +9.6% |
| CAGR 5Y | +4.8% | +2.7% |
| Sharpe 3Y | 0.22 | 0.38 |
| Volatility 1Y | 14.63% | 19.75% |
| Max drawdown | -28.40% | -39.82% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IYH and IBB
Explore further